ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Edgar Amorin
Edgar Amorin, M.D., TCVS, Ph.D.
Background
San Fernando Medical School . San Marcos University (MD,1981)
Cayetano Heredia University General & Oncology Surgery (Residency,1982-1986)
National Institute of Neoplastic Diseases Thoracic Oncology Surgery (Fellowship, 1986 -1987)
Mount Sinai Medical Center TCVS Fla. (Miami, 1987)
Memorial Sloan Kettering Cancer Center. Thoracic Oncology. NY (New York, 1987-1988)
UT MD Anderson Cancer Center Thoracic Oncology.Tx (Houston, 1988)
National Institute of Neoplastic Diseases. Oncology Thoracic Surgery (Attending/Chief/Staff)
Clinica Ricardo Palma. Thoracic & Cardiovascular Surgery.(Ongoing)
Other Interests
Lung Cancer
Pulmonary metastasis
Mediastinal tumors
Transthoracic Needle Biopsy
Video Assisted Thoracic Surgery
Esophageal cancer
Chest wall tumor Resection & Reconstruction
Pleural malignancies - Mesothelioma & Pleural effusions
Thymectomy for Miastenia Gravis
Medical Ethics & Phylosophy
2nd Opinion
Research
- INVESTIGADOR ASOCIADO Estudio de Fase II de Brostaciclina (PNU-166196ª) en pacientes con cáncer de pulmón a células no pequeñas (NSCLC) avanzado, refractario o resistente a la quimioterapia basado en platino. Protocolo No. 196-ONC-0100-005, Junio 22, 2001. Pharmacia&Upjohn., 2001
- INVESTIGADOR ASOCIADO An open label randomized phaseII/III study comparing two combination modalities of IV hmr1275 (flavopiridol) and iv docetaxel (taxotere) with iv docetaxel (taxotere) alone in patiens with non – small cell lung cancer (NSCLC) previously treated with platinum – based chemotherapy. Hmr1275b/3001, 2002.
- INVESTIGADOR ASOCIADO SCH 066336 FPT. G-P01901 a Phase III Randomized Study of Lonafarnib in Combination with Paclitaxel and Carboplatin in Patients with Non Small Cell Lung Cancer. Schering Plough. 2002.
- INVESTIGADOR ASOCIADO A Randomized Phase II of Paclitaxel – Carboplatin or Gemcitabine – Cisplatin In ECOG Performance Status 2 Non – Small Lung Cancer Patients
E1599. ECOG. May, 2002.
- INVESTIGADOR ASOCIADO A phase III trial of carboplatino, paclitaxel and thoracic radiotherapy, with or without thalidomide, in patients with stage III NSCLC, E.C.O.G., 2003
- INVESTIGADOR ASOCIADO A phase III trial of carboplatino, paclitaxel and thoracic radiotherapy, with or without thalidomide, in patients with stage III NSCLC, Eastern Cooperative Oncology Group.E3598 EPP E3598 CTSU E3598, 2003.
- INVESTIGADOR ASOCIADO A phase II study of cisplatino plus etoposide (PE) plus Bevacizumab (NSC # 0704865) for previously untreated extensive stage small cell lung cancer E3501, 2004.
- INVESTIGADOR ASOCIADO A Phase II Open – Label Study Evaluating Clinical Efficacy, Safety, Pharmacokinetic and Pharmacodynamic effects of Lapatinib (GW572016) in patients with relapsed Adenocarcinoma Of Esophagus, Including Tumors of the Gastroesophageal Junction And Gastric Cardia..EGF102980. Glaxo Smith Kline. May 2005.
- INVESTIGADOR PRINCIPAL Estudio FaseIII Internacional, randomizado, doble ciego, de grupos paralelos, multicéntrico, para evaluar la eficacia de ZD6474 (ZACTIMA) más la mejor atención de soporte vs. placebo más la mejor atención de soporte en pacientes con cáncer de pulmón no microcítico (CPNM) localmente avanzado o metastático (EstadíoIIIb- IV) luego del tratamiento previo con inhibidor de la tirosin quinasa del receptor del factor de crecimiento epidérmico (EGFR TKI). STUDY 44 ASTRAZENECA, San Francisco. USA, 21st – 22nd September 2006.
- INVESTIGADOR PRINCIPAL Un estudio de fase II/III, doble ciego de Paclitaxel mas Carboplatino en combinación con VORINOSTAT o Placebo en pacientes con carcinoma broncopulmonar de células pequeñas (NSCLC) Estadío IIIB (con efusión pleural) o estadío IV. MK – 0683 Protocolo 056 MERCK SHARP & DOHME, Berlin – Alemania. 16 – 17 Abril. 2007 – 2009.
- INVESTIGADOR PRINCIPAL Estudio Clínico Fase III. En Cáncer de Pulmón a células no pequeñas 2010. Clínica Ricardo Palma. En curso.
Additional Educational Information
Internship Universidad Nacional Mayor de San Marcos
MD Universidad Nacional Mayor de San Marcos
Speciality Oncology Surgery / Thoracic Surgeon & CV/ Universidad Cayetano Heredia
Master Ethics and Medical Bioethics. Universidad Nacional Mayor de San Marcos
PhD Malingnant melanoma of the trunk Universidad Nacional Mayor de San Marcos
Practice Areas
- Thoracic
- Cancer
- Chest wall
- Diaphragm
- Education
- Esophagus
- Professional Affairs
- Ethics
- Lung
- VATS
- Mediastinum
- Minimally Invasive
- Pericardium
- Pleura
- Thoracic
- Trachea and bronchi